Primary hepatic lymphoma

Primary hepatic lymphoma (PHL) is rare accounting for roughly 100 described cases. If it is being considered as a diagnosis, distal lymphadenopathy, splenomegaly, bone marrow disease, and leukaemia should not be present for at least 6 months after the liver tumour is detected (see: secondary hepatic lymphoma4.

Rare presentation of lymphoma (<1% of all Non-Hodgkin lymphomas).

By way of contrast, according to one source, diffuse large B-cell lymphoma (DLBCL) affects around 7 out of 100,000 people annually in the United States, with potential for secondary involvement of the liver, so this is a much more common cause of hepatic lymphoma.

The most common presentation includes abdominal pain, jaundice, and weight loss. The majority of patients will have elevated liver enzymes, which may be normal. The typical age of presentation is middle age around 55 years. It has a male preponderance.

The exact cause of this primary hepatic lymphoma is still unclear, however, it is primarily found in immunocompromised patients such as AIDS/HIVcongential immunodeficiency, immunosuppressant therapy for organ transplant and collagen vascular disease. Reports have also shown infections as a cause such as EBVHIVhepatitis C and hepatitis B with chronic hepatitis and cirrhosis.

The majority of cases of primary liver lymphoma are diffuse large B-cell lymphoma. Other histologic types include peripheral T-cell leukaemia/lymphoma-not-otherwise-specified, follicular lymphoma, mantle cell lymphoma, or Burkitt lymphoma.

Primary hepatic lymphoma most commonly is represented by a solitary mass (53-65%). PHL does not have characteristic radiographic features and can often be mistaken for other liver tumours. Liver biopsy is the most specific way of making the diagnosis.

Usually the initial radiologic test performed:

  • typically hypoechoic to the liver parenchyma probably due to high cellularity and lack of background stroma
  • rarely, they may be so hypoechoic that they may appear similar to a cyst
  • occasionally have a "target" appearance with a central hyperechogenicity and outer hypoechogenicity
  • increased peripheral vascularity with colour Doppler
  • frequently a single (~60%), solid, hypoattenuating (due to hypovascularity) lesion as opposed to secondary lymphoma which can be more diffusely infiltrating 1,2
  • there can be a large variation in size, but PHL tends to have dominant masses, opposed to secondary lymphomatous involvement of the liver, which tends to be more diffuse
  • variable contrast enhancement on CT, but tend to be hypoenhancing relative to liver on all phases, with no enhancement in some cases
  • an ill-defined mass at the porta hepatis is possible
  • haemorrhage, necrosis, and rim-enhancement are possible

 MRI findings depend on the extent of infiltration.

  • T1: typically hypointense relative to remainder of liver
  • T2: often shows variable intensity
  • T1 C+ (Gd):  there is poor gadolinium enhancement of these lesions, but they may show faint peripheral rim enhancement 
  • DWI/ADC: restricts diffusion

Signal characteristics are almost identical to secondary lymphomatous involvement but manifestation as a single solid mass may favour towards a primary hepatic lymphoma 1.

PET/CT is useful in making the diagnosis and can also be used for staging. 

    • ​avid FDG uptake of the lymphomatous mass in the liver
    • can show or exclude extrahepatic sites of lymphoma with a high degree of sensitivity

PHL is primarily treated with chemotherapy. The most common chemotherapy regimen for advanced diffuse large B-cell lymphoma (DLBCL) is called R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone). In the United States, this regimen is generally given every three weeks for 6 to 8 cycles. Other treatment options include radiation therapy or surgery.  

Hepatobiliary pathology
Share article

Article information

rID: 7581
Synonyms or Alternate Spellings:
  • Primary hepatic lymphoma (PHL)

Support Radiopaedia and see fewer ads

Cases and figures

  • Drag
    Tumor cells with ...
    Case 1: histology
    Drag here to reorder.
  • Drag
    Case 1: on CT
    Drag here to reorder.
  • Drag
    Color Doppler ima...
    Case 1: on ultrasound with colour doppler
    Drag here to reorder.
  • Drag
    Coronal image of ...
    Case 1: on PET/CT
    Drag here to reorder.
  • Updating… Please wait.

    Alert accept

    Error Unable to process the form. Check for errors and try again.

    Alert accept Thank you for updating your details.